Cardiovascular Autonomic Neuropathy Is Associated with Microalbuminuria in Older Patients with Type 2 Diabetes

Diabetes Care

Volumn 27, Issue 4, 2004, Pages 972-977

  Moran, Andrew ^a   Palmas, Walter ^a   Field, Lesley ^a   Bhattarai, Jyoti ^b   Schwartz, Joseph E ^c   Weinstock, Ruth S ^b,d   Shea, Steven ^a,e,f  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d SYRACUSE VA MEDICAL CENTER   (United States)

^e Columbia University ^*  (United States)

^f Division of General Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; FEMALE; HEART RATE VARIABILITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ALBUMINURIA; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; FEMALE; HEART RATE; HUMANS; MALE; MULTIVARIATE ANALYSIS;

EID: 1842590369     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.4.972     Document Type: Article

References (31)

1. Neil HAW, Thompson AV, John S, McCarthy ST, Mann JI: Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 6:20-24, 1989
2. Zeigler D: The epidemiology of diabetic neuropathy. J Diabetes Complications 6: 49-57, 1992
3. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease. Diabetes Care 24:1793-1798, 2001
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
5. Chen HS, Hwu CM, Kuo BI, Chiang SC, Kwok CF, Lee SH, Lee YS, Weih MJ, Hsiao LC, Lin SH, Ho LT: Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med 18:268-273, 2001
6. Ewing D, Martyn C, Young R, Clarke BF: The value of cardiovascular autonomic function tests: 10 years of experience in diabetes. Diabetes Care 8:491-498, 1985
7. Kahn R: Proceedings of a consensus development conference on standardized measures in diabetic neuropathy: autonomic nervous system testing. Diabetes Care 15:1095-1103, 1992
8. Smulders Y, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer C: Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasion subjects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study. Diabetes Care 23:1368-1375, 2000
9. Zander E, Schulz B, Heinke P, Grimmberger E, Zander G: Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care 12:259-264, 1989
10. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G: Relationship between autonomic neuropathy, 24-hour blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 17:578-584, 1994
11. Sundvist G, Lilja B: Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 16:773-779, 1993
12. Weinrauch LA, Kennedy FP, Gleason RE, Keogh J, D'Elia JA: Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control. Am J Hypertens 11:302-308, 1998
13. Forsblom CM, Groop PH, Ekstrand A, Totterman KJ, Sane T, Saloranta C, Groop L: Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 21:1932-1938, 1998
14. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426, 2001
15. Nakano S, Uchida K, Kigoshi T, Azukizawa S, Iwasaki R, Kaneko M, Morimoto S: Circadian rhythm of blood pressure in normotensive NIDDM subjects: its relationship to microvascular complications. Diabetes Care 14:707-711, 1991
16. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347:797-805, 2002
17. Shea S, Starren J, Weinstock RS, Knudson PE, Teresi J, Holmes D, Palmas W, Field L, Goland R, Tuck C, Hripcsak G, Capps L, Liss D: Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design. J Am Med Informat Assoc 9:49-62, 2002
18. Pickering TG: Ambulatory Blood Pressure. Redmond, WA, Spacelabs Medical, 1994
19. Roman MJ, Pickering TG, Schwartz JE, Cavallini MC, Pini R, Devereux RB: Is the absence of normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage? J Hypertens 15:969-978, 1997
20. Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K: Relationship between extreme dippers and orthostatic hypotension in elderly hypertensive patients. Hypertension 31:77-92, 1998
21. Risk M, Bril V, Broadbridge C, Cohen A: Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther 3:63-76, 2001
22. Consensus Statement: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 37:1000-1004, 1988
23. American Diabetes Association: Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus (Consensus Statement). Diabetes Care 17:1357-1361, 1994
24. Hilsted J: Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies. Diabetes 31:730-737, 1982
25. Winocour PH, Dhar H, Anderson DC: The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabet Med 3:436-440, 1986
26. Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E: Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent diabetic nephropathy? J Am Soc Nephrol 12:602-605, 2001
27. Niskansen LK, Penttila I, Parviainen M, Uusitupa MIJ: Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care 19:486-493, 1996
28. Gerstein HC, Mann JFE, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, Joyce C, Rashkow A, Young J, Zinman B, Yusuf S: Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation study. Diabetes Care 23 (Suppl. 2):B35-B39, 2000
29. Torbjornsdotter TB, Jaremko GA, Berg UB: Ambulatory blood pressure and heart rate in relation to kidney structure and metabolic control in adolescents with type 1 diabetes. Diabetologia 44:865-873, 2001
30. Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE: Albuminuria and 24-hour ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients: a longitudinal study. Diabetes Care 18:1434-1441, 1995
31. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20:516-519, 1997